|
|
|
|
| LEADER |
00877nas a22002172u 4500 |
| 001 |
10038775 |
| 003 |
upatras |
| 005 |
20210117195558.0 |
| 008 |
010124c2001 ne r p gre |
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000
|7 0
|9 19625
|a LISP
|b LISP
|c SER
|d 2016-04-24
|i 1933
|l 0
|o 615.1
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y JNL
|
| 999 |
|
|
|c 11000
|d 11000
|
| 022 |
|
|
|a 0928-0987
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 082 |
0 |
4 |
|a 615.1
|
| 245 |
1 |
0 |
|a European journal of pharmaceutical sciences
|h [Περιοδικό]
|
| 260 |
|
|
|a Amsterdam
|b Elevier
|c 2001
|
| 310 |
|
|
|a Μηνιαίο
|
| 362 |
0 |
|
|a 12(2001)-
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b Θ
|k ΠΕΡ
|h 615.1
|m 1933
|t 1
|3 Vol.12:No.1(2001:JAN)-Vol.13:No.2(2001:JUN), Vol.13:No.4(2001:AUG)-Vol.16:No.3(2002:JUL)
|
| 866 |
|
|
|a Vol.12:No.1(2001:JAN)-Vol.13:No.2(2001:JUN), Vol.13:No.4(2001:AUG)-Vol.16:No.3(2002:JUL)
|
| 942 |
|
|
|2 ddc
|s 1
|c JNL
|
